There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Pfizer (PFE – Research Report), Vertex Pharmaceuticals (VRTX – Research Report) and Amgen (AMGN – Research Report) with bullish sentiments.
Pfizer (PFE)
In a report released today, Louise Chen from Cantor Fitzgerald maintained a Buy rating on Pfizer, with a price target of $45.00. The company’s shares closed last Friday at $25.86, close to its 52-week low of $25.61.
According to TipRanks.com, Chen has 0 stars on 0-5 stars ranking scale with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Pfizer with a $31.57 average price target, implying a 20.3% upside from current levels. In a report issued on April 10, Truist Financial also maintained a Buy rating on the stock.
See the top stocks recommended by analysts >>
Vertex Pharmaceuticals (VRTX)
Oppenheimer analyst Hartaj Singh maintained a Buy rating on Vertex Pharmaceuticals today and set a price target of $500.00. The company’s shares closed last Friday at $396.55.
According to TipRanks.com, Singh is a 5-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Vertex Pharmaceuticals with a $455.29 average price target, representing a 14.8% upside. In a report issued on April 11, William Blair also initiated coverage with a Buy rating on the stock.
Amgen (AMGN)
Oppenheimer analyst Jay Olson maintained a Buy rating on Amgen today and set a price target of $380.00. The company’s shares closed last Friday at $267.28.
According to TipRanks.com, Olson is a 5-star analyst with an average return of
Currently, the analyst consensus on Amgen is a Moderate Buy with an average price target of $311.72, implying a 16.0% upside from current levels. In a report issued on April 3, RBC Capital also maintained a Buy rating on the stock with a $329.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on PFE:
